Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE)

NCT04519294 — Not applicable, Completed, 132 participants, Calyxo, Inc.

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Prospective, Randomized Study to Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation(SURE)Using the CVAC™ Aspiration System Compared to Basketing for the Removal of Renal Calculi Following Laser Lithotripsy

RegistryNCT04519294
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment132 (Actual)
SponsorCalyxo, Inc. (Industry)
ConditionsKidney Stone, Renal Stone, Urolithiasis
InterventionsSURE, Standard Ureteroscopy (Basketing) (Device)
Datesstart 2021-06-16, primary completion 2023-01-30, completion 2025-04-30, first posted 2020-08-19, last updated 2026-02-27
Locations11 sites in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Kidney Stone All trials for Renal Stone All trials of SURE All trials of Standard Ureteroscopy (Basketing)

-Summary

The purpose of the study is to compare the effects, good and/or bad, of a treatment for removing kidney stones called the SURE procedure for stone evacuation to the standard treatment using a basket for stone removal.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
SUREActive comparatorDevice: SURE
Standard Ureteroscopy (Basketing)Active comparatorDevice: Standard Ureteroscopy (Basketing)
  • SURE (Device): The SURE stone evacuation procedure is a technique intended to more easily and completely remove a kidney stone during a kidney stone treatment. The urologist first uses a laser to break the kidney stone into small pieces. Then with the SURE procedure, the pieces are gently vacuumed out of the kidney instead of retrieving the pieces one-by-one with a basket or leaving them to pass naturally in the urine. Basketing is allowed and might be used with the SURE procedure, if needed to remove some small stones.
  • Standard Ureteroscopy (Basketing) (Device): This is a treatment in which the urologist uses a laser to break a kidney stone into small pieces and then uses a tool called a basket to retrieve the pieces one at a time.

+Outcome measures

Primary outcomes

  • Stone Free Rate (SFR) - Zero Fragments [30 Days]: The primary efficacy endpoint is the SFR, where stone free status is defined as zero residual fragments at 30 days observed on non-contrast CT (NCCT) (1.25mm slice thickness) by blinded central reviewer(s). The SFR is calculated by determining the number of subjects in each treatment arm with a stone free status of zero fragments and dividing that by the total number of subjects treated in the respective treatment arm.

Secondary outcomes

  • Residual Stone Volume (RSV) [30 Days]: A continuous quantitative measure of remaining stone volume following intervention, assessed via post-procedural imaging on NCCT (1.25mm slice thickness) by blinded central reviewer(s).
  • Stone Clearance (% Reduction in Stone Volume) [30 Days]: Percent reduction (\[Baseline stone volume- 30-Day stone volume\] / Baseline stone volume) in stone volume following intervention, assessed via post-procedural imaging on NCCT (1.25mm slice thickness) by blinded central reviewer(s). A positive result indicates a decrease in stone volume removed during the procedure; a negative value indicates an increase in stone volume following the procedure.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Candidate for ureteroscopy with laser lithotripsy;
* Presence of renal stone(s);
* Be willing and able to return for all study-related follow up procedures; and,
* Have been informed of the nature of the study, agreeing to its requirements, and have signed the IRB approved informed consent.

Exclusion Criteria:

* BMI > 45;
* Significant comorbidities;
* Bladder, ureteral or kidney abnormalities;
* Pregnant individuals; or
* Unable to meet the treatment and follow up protocol requirements.

+Posted results

Participant flow

MilestoneSUREStandard Ureteroscopy (Basketing)
Started4655
Completed4350
Not completed35

Outcome results

  • Stone Free Rate (SFR) - Zero Fragments (Primary), Number, % subjects: SURE 48; Standard Ureteroscopy (Basketing) 49
  • Residual Stone Volume (RSV) (Secondary), Mean, mm^3: SURE 14.3 +/- 30.9; Standard Ureteroscopy (Basketing) 70.2 +/- 144.9
  • Stone Clearance (% Reduction in Stone Volume) (Secondary), Mean, percent reduction (%): SURE 97.1 +/- 5.4; Standard Ureteroscopy (Basketing) 93.3 +/- 11.7

Adverse events

Time frame: 30 Day

ArmDeathsSerious adverse eventsOther adverse events
SURE0/67 (0.0%)1/67 (1.5%)4/67 (6.0%)
Standard Ureteroscopy (Basketing)0/65 (0.0%)2/65 (3.1%)5/65 (7.7%)

Serious adverse events by term

TermOrgan systemSUREStandard Ureteroscopy (Basketing)
Sepsis Requiring HospitalizationRenal and urinary disorders1/672/65

Other adverse events by term

TermOrgan systemSUREStandard Ureteroscopy (Basketing)
Ureteral DamageRenal and urinary disorders4/675/65

+Locations (11)

FacilityCityCountryStatus
Mayo ClinicPhoenix, ArizonaUnited States
Arizona Institute of UrologyTucson, ArizonaUnited States
Johns HopkinsBaltimore, MarylandUnited States
New Jersey UrologyVoorhees Township, New JerseyUnited States
Albany Medical CollegeAlbany, New YorkUnited States
Duke UniversityDurham, North CarolinaUnited States
Prisma HealthGreenville, South CarolinaUnited States
Urology AustinAustin, TexasUnited States
Dell Medical School, The University of Texas at AustinAustin, TexasUnited States
UT Southwestern Medical CenterDallas, TexasUnited States
Urology of VirginiaVirginia Beach, VirginiaUnited States

+Study documents